Clinical trial
Locally ablatiVe therApy in oLigO-pRogressive sOlid tUmorS (VALOROUS)
NCT06103669
Study timeline
Study start (actual)2023-10-05Date precision: day
Registry last updated2026-07-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerverified · MONDO: breast cancer
Oligoprogressiveunresolved
Sarcomaverified · MONDO: sarcoma
Other Cancerunresolved
Interventions
Ablative local therapyDEVICE
Sponsors & collaborators
University of California, Davislead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06103669 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.